Azoxystrobin Reduces Oral Carcinogenesis by Suppressing Mitochondrial Complex III Activity and Inducing Apoptosis.
Hui ChenLingyu LiYunping LuYajun ShenMin ZhangLihua GeMin WangJing YangZhenchuan TianXiaofei TangPublished in: Cancer management and research (2020)
AZOX inhibited the development of oral cancer through specific inhibition of the activity of mitochondrial complex III, which led to ROS accumulation, and MMP decrease, ultimately inducing apoptosis. AZOX may be a novel agent for the prevention and treatment of OSCC.